Literature DB >> 3117905

Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.

S Morioka1, G S Lazarus, P J Jensen.   

Abstract

Pemphigus IgG induces acantholysis in skin organ culture without the involvement of complement. Urokinase-type plasminogen activator, a proteolytic enzyme, has been implicated in the development of acantholysis. To test this hypothesis, we prepared a rabbit anti-urokinase antibody, which inhibited the plasminogen activator activity in normal human epidermis and in cultured keratinocytes. When added to skin organ cultures along with pemphigus IgG, anti-urokinase IgG completely prevented the development of acantholysis. Normal or preimmune rabbit IgG had no effect on pemphigus IgG-induced acantholysis. Plasminogen activator converts the zymogen plasminogen to its active form plasmin, a broad specificity serine proteinase. When high concentrations of plasminogen alone were added to skin organ culture, acantholysis of the pemphigus foliaceous type was induced. Anti-urokinase antibody also inhibited plasminogen-induced acantholysis. These results strongly support a pivotal role for plasminogen activator in the development of acantholysis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117905     DOI: 10.1111/1523-1747.ep12460937

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  13 in total

1.  Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.

Authors:  S Stoll; W Garner; J Elder
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

3.  Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis.

Authors:  J Wang; J Kwon; X Ding; J A Fairley; D T Woodley; L S Chan
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Autoimmunity to desmocollin 3 in pemphigus vulgaris.

Authors:  Xuming Mao; Arielle R Nagler; Sara A Farber; Eun Jung Choi; Lauren H Jackson; Kristin M Leiferman; Norito Ishii; Takashi Hashimoto; Masayuki Amagai; John J Zone; Aimee S Payne
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

5.  Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.

Authors:  M G Mahoney; Z Wang; K Rothenberger; P J Koch; M Amagai; J R Stanley
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.

Authors:  J Reinartz; H Näher; H Mai; M D Kramer
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis.

Authors:  W Glinski; M Pierozynska-Dubowska; M Glinska-Ferenz; S Jablońska
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

8.  Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion.

Authors:  J Varani; B Burmeister; R G Sitrin; S B Shollenberger; D R Inman; S E Fligiel; D F Gibbs; K Johnson
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

9.  Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression.

Authors:  Isabelle Bolon; Hong-Ming Zhou; Yves Charron; Annelise Wohlwend; Jean-Dominique Vassalli
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Endemic pemphigus over a century: Part II.

Authors:  Ana María Abréu-Vélez; Ana Maria Roselino; Michael S Howard; Iara J de Messias Reason
Journal:  N Am J Med Sci       Date:  2010-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.